tutkimus Joukkueet - Stabilis 4.0

Viimeisin päivitys :
27/11/2024

tutkimus Joukkueet - Merck and Co

pdf

Yhdysvallat

lääkelaboratorio

Merck and Co

West Point

Email

maria_tsiouris@merck.com

Viitteet

Viitteet

(7)

1

Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag.
Sundaramurthi P, Sean Chadwick S, Narasimhan C. (Prakash.sundaramurthi@merck.com)
J Oncol Pharm Practice - 2020 - ; 26, 3: 641-646.

2

Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device.
Tsiouris M, Ulmer M, Yurcho J F, Hooper K L, Gui M. ()
Int J Pharm Compound - 2010 - ; 14, 5 : 436-439.

3

Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions.
McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ. (michael_mcquade@ merck.com)
Am J Health-Syst Pharm - 2004 - ; 61: 38-45.

4

Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.
Bergquist PA, Manas D, Hunke WA, Reed RA. ()
Am J Health-Syst Pharm - 2001 - ; 58: 1218-1223.

5

Stability of tirofiban hydrochloride in three commonly used IV solutions and polyvinyl chloride administration sets.
Bergquist PA, Zimmermann J, Kenney RR, Han RYH, Hunke WA. ()
Am J Health-Syst Pharm - 1999 - ; 56: 1627-1629.

6

Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.
Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M. ()
J Clin Pharm Ther - 1999 - ; 24: 125-132.

7

Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
Bigley FP, Forsyth RJ, Henley MW. ()
Am J Hosp Pharm - 1986 - ; 43: 2803-2809.

Luettelo yhdisteistä

molekyylit tutkittu

(22)

Mentions Légales